Adam Brufsky, MD

Adam Brufsky, MD

Episodes

Specialty:

All

Year:

All

EP. 1: Neratinib in the Adjuvant Setting The Paradigm Shift for HER2+ Breast Cancer Neratinib Toxicity Management

February 6th 2017

EP. 2: Neratinib for Metastatic Breast Cancer

February 6th 2017

EP. 3: Personal Experience with Neratinib

February 6th 2017

EP. 4: CDK4/6 Inhibitors for HR+ Breast Cancer; Emergence of Ribociclib

February 6th 2017

EP. 5: Sequencing Therapies for HR+ Metastatic Breast Cancer

February 6th 2017

Trending on OncLive

FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

Dr Skoulidis on First-Line Divarasib Plus Pembrolizumab in KRAS G12C+ NSCLC

Dr Cortés on Developing CD47 as a Biomarker in Pretreated HER2+ Breast Cancer

Enzalutamide Plus Talazoparib Shows Activity in mHSPC